Skip to main content
IONS
NASDAQ Life Sciences

AstraZeneca-Ionis Heart Drug Wainua Fails Late-Stage Trial Main Goal

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$86.14
Mkt Cap
$13.958B
52W Low
$40.03
52W High
$86.74
52W Position info
115% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

IONS has more than doubled off its 52-week low of $40.03.

Summary

The AstraZeneca-Ionis partnered drug, Wainua, failed to meet its primary endpoint in a late-stage trial for heart disease, specifically in reducing cardiovascular deaths and recurring heart problems. This is a significant setback for Ionis, as late-stage drug failures represent a loss of substantial R&D investment and potential future revenue. The news contrasts sharply with a recent series of positive developments for Ionis, including strong Q1 results, multiple positive clinical readouts, and an FDA approval for TRYNGOLZA, which had driven the stock near its 52-week high.

At the time of this announcement, IONS was trading at $86.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14B. The 52-week trading range was $40.03 to $86.74. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Oct 23, 2026, 1:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.93
Real-time Price: $38.50 info
Change: -$4.43 (-10%) info
Market Cap: $6.448B info
IONS
Oct 20, 2026, 9:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $45.20
Real-time Price: $38.50 info
Change: -$6.70 (-15%) info
Market Cap: $6.448B info
IONS
Oct 16, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.56
Real-time Price: $38.50 info
Change: -$5.06 (-12%) info
Market Cap: $6.448B info
IONS
Sep 23, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $45.75
Real-time Price: $38.50 info
Change: -$7.25 (-16%) info
Market Cap: $6.448B info
IONS
Sep 22, 2026, 8:36 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $46.42
Real-time Price: $38.50 info
Change: -$7.92 (-17%) info
Market Cap: $6.448B info